Immediate Administration of Tolvaptan Prevents the Exacerbation of Acute Kidney Injury and Improves the Mid-Term Prognosis of Patients With Severely Decompensated Acute Heart Failure-Reference-Cited by-同舟云学术

Immediate Administration of Tolvaptan Prevents the Exacerbation of Acute Kidney Injury and Improves the Mid-Term Prognosis of Patients With Severely Decompensated Acute Heart Failure

Published:2014 Issue:4 Volume:78 Page:911-921
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Shirakabe Akihiro¹,Hata Noritake¹,Yamamoto Masanori¹,Kobayashi Nobuaki¹,Shinada Takuro¹,Tomita Kazunori¹,Tsurumi Masafumi¹,Matsushita Masato¹,Okazaki Hirotake¹,Yamamoto Yoshiya¹,Yokoyama Shinya¹,Asai Kuniya²,Shimizu Wataru²

Affiliation:

1. Division of Intensive Care Unit, Chiba Hokusoh Hospital, Nippon Medical School

2. Department of Cardiovascular Medicine, Nippon Medical School

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/78/4/78_CJ-13-1255/_pdf

Reference30 articles.

1. Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction

2. Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction